Microfluidic Assisted One-Step Fabrication of Porous Silicon@acetalated Dextran Nanocomposites for Precisely Controlled Combination Chemotherapy.

Dongfei Liu,Hongbo Zhang,Ermei Mäkilä,Jin Fan,Bárbara Herranz-Blanco,Chang-Fang Wang,Ricardo Rosa,António J Ribeiro,Jarno Salonen,Jouni Hirvonen,Hélder A Santos
DOI: https://doi.org/10.1016/j.biomaterials.2014.10.079
IF: 14
2014-01-01
Biomaterials
Abstract:An advanced nanocomposite consisting of an encapsulated porous silicon (PSi) nanoparticle and an acid-degradable acetalated dextran (AcDX) matrix (nano-in-nano), was efficiently fabricated by a one-step microfluidic self-assembly approach. The obtained nano-in-nano PSi@AcDX composites showed improved surface smoothness, homogeneous size distribution, and considerably enhanced cytocompatibility. Furthermore, multiple drugs with different physicochemical properties have been simultaneously loaded into the nanocomposites with a ratiometric control. The release kinetics of all the payloads was predominantly controlled by the decomposition rate of the outer AcDX matrix. To facilitate the intracellular drug delivery, a nona-arginine cell-penetrating peptide (CPP) was chemically conjugated onto the surface of the nanocomposites by oxime click chemistry. Taking advantage of the significantly improved cell uptake, the proliferation of two breast cancer cell lines was markedly inhibited by the CPP-functionalized multidrug-loaded nanocomposites. Overall, this nano-in-nano PSi@polymer composite prepared by the microfluidic self-assembly approach is a universal platform for nanoparticles encapsulation and precisely controlled combination chemotherapy.
What problem does this paper attempt to address?